
Antares Pharma
Revenue-generating product focused specialty pharmaceutical company.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | $960m Valuation: $960m | Acquisition | |
Total Funding | 000k |
Related Content
Antares Pharma is a specialty pharmaceutical company that merges drug development expertise with proprietary delivery technology to create safe and effective medicines. The company primarily focuses on self-injection pharmaceutical products and technologies, targeting therapeutic areas such as rheumatology, urology, endocrinology, and neurology. Antares Pharma aims to improve dosing accuracy, reduce side effects, and enhance patient compliance and outcomes through innovative therapies. The company serves patients, physicians, partners, and stakeholders by combining pharmaceutical and medical device knowledge to produce optimal treatment options. Antares Pharma operates in the pharmaceutical market and generates revenue through the development, manufacturing, and sale of its proprietary drug delivery systems and pharmaceutical products. The business model is centered on providing specialized drug delivery solutions that meet the needs of its diverse client base, including healthcare providers and patients.
Keywords: specialty pharmaceutical, self-injection, drug delivery, rheumatology, urology, endocrinology, neurology, dosing accuracy, patient compliance, proprietary technology.